Celldex Therapeutics, Inc. (CLDX)
$28.25-4.01%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.9B
- Beta
- 0.90
- P/E (TTM)
- -6.48
- Short % float
- 17.94%
- Days to cover
- 3.8
- SI change
- +22.9%
- 1W
- -8.90%
- 1M
- -27.90%
- vs SPY 1W
- -8.76%
- vs SPY 1M
- -30.40%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on CLDX?
- LOPJLB’s latest quantitative signal on Celldex Therapeutics, Inc. (CLDX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CLDX in?
- Celldex Therapeutics, Inc. (CLDX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Celldex Therapeutics, Inc. (CLDX) do?
- Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to a…